Projects and Grants per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Post Doctoral Fellow, Upstate Medical Center
2021
Residency, Vincent Hospital, Worcester, Massachusetts
2019
Doctor of Medicine, University Of Colonbo
2012
Fingerprint
Dive into the research topics where Paramarajan Piranavan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration from the last 5 years on country level. Dive into details by clicking on the dots.
Projects & Grants
- 4 Active
-
SNAC: Systemic Lupus Erythematosus (SLE) Treatment with N-acetylcysteine (NAC)
Piranavan, P. (PI)
Research Foundation of State University of New York
1/28/25 → 5/31/26
Project: Research project
-
Rapcabtagene: A Phase 2, Adaptive, Randomized, Open-Label, Assessor-Blinded Active-Controlled Study to Evaluate the Efficacy and Safety of Rapcabtagene Autoleucel vs. SOC in Patients Suffering from Systemic Lupus Erythematosus (SLE) with Active, Refractor
Piranavan, P. (PI), Ahmed, S. (CoI), Alkilany, R. (CoI) & Qasrawi, A. (CoI)
11/8/24 → 12/21/30
Project: Research project
-
TScan: A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients with Autoimmune Disease
Flomenhoft, D. (PI) & Piranavan, P. (CoI)
12/15/22 → 1/8/27
Project: Research project
-
Chorea as an initial and solitary manifestation of systemic lupus erythematosus with antiphospholipid syndrome in an elderly man
Javed, F. & Piranavan, P., Jan 30 2024, In: BMJ Case Reports. 17, 1, e257086.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Nirmatrelvir plus ritonavir in patients with underlying rheumatological diseases, in preventing COVID-19 related hospitalization and death
Javed, F., Mangino, A. A. & Piranavan, P., Dec 2024, In: Advances in Rheumatology. 64, 1, 50.Research output: Contribution to journal › Letter › peer-review
Open Access -
Pitfalls in antiphospholipid antibody testing: specifically interference from anticoagulation
Ali, H., Buechler, C. R., Sanaullah, O. & Piranavan, P., Feb 2024, In: Clinical Rheumatology. 43, 2, p. 821-823 3 p.Research output: Contribution to journal › Letter › peer-review
-
Embolic myocardial infarction with cardiac arrest as an initial manifestation of non-bacterial thrombotic endocarditis
Hansen, A. C., Piranavan, P., Kundu, A., El-Dalati, S. A. & Ahmed, T., Nov 1 2023, In: BMJ Case Reports. 16, 11, e257466.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Improvement of renal and non-renal SLE outcome measures on sirolimus therapy – A 21-year follow-up study of 73 patients
Piranavan, P. & Perl, A., Aug 2021, In: Clinical Immunology. 229, 108781.Research output: Contribution to journal › Article › peer-review
Open Access27 Scopus citations